Evidence map›Paper›PMID 37115777›Full record

ArticlePloS one2023

A standardized method for plasma extracellular vesicle isolation and size distribution analysis.

J Nathaniel Diehl, Amelia Ray, Lauren B Collins, Andrew Peterson, Kyle C Alexander, Jacob G Boutros, John S Ikonomidis, Adam W Akerman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

J Nathaniel DiehlUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.ORCID 0000-0002-7309-0903
Amelia RayUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.ORCID 0000-0001-9817-2828
Lauren B CollinsUniversity of North Carolina School of Medicine, Chapel Hill, North Carolina, United States of America.
Andrew PetersonDepartment of Surgery, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States of America.
Kyle C AlexanderDepartment of Surgery, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States of America.
Jacob G BoutrosCampbell University School of Osteopathic Medicine, Lillington, North Carolina, United States of America.
John S IkonomidisDepartment of Surgery, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States of America.
Adam W AkermanDepartment of Surgery, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina, United States of America.
University of North Carolina at Chapel Hill · USCampbell University · US

Funding

Transmembrane Proteolytic Induction and Thoracic AneurysmsR01HL102121 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IKONOMIDIS, JOHN S · 2011 to 2019
$3.0M
Enhanced Biochemical Monitoring for Aortic Aneurysm DiseaseR01HL169390 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Adam William Akerman · 2023 to 2026
$2.6M
Device-Based Pathway Intervention: Mechanistic Study of Cellular Localization of Proteolytic Enzymes in Thoracic Aortic Aneurysm DiseaseR56HL161454 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IKONOMIDIS, JOHN S · 2022 to 2022
$686k
Exploration of key proteases and validation of biomarkers in genetically triggered thoracic aortic aneurysmsR21HL148363 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI IKONOMIDIS, JOHN S · 2019 to 2020
$233k
NHLBI NIH HHS R01 HL102121NHLBI NIH HHS R01 HL169390NHLBI NIH HHS R21 HL148363NHLBI NIH HHS R56 HL161454
6 · The paper itself

Abstract

The following protocol describes our workflow for isolation and quantification of plasma extracellular vesicles (EVs). It requires limited sample volume so that the scientific value of specimens is maximized. These steps include isolation of vesicles by automated size exclusion chromatography and quantification by tunable resistive pulse sensing. This workflow optimizes reproducibility by minimizing variations in processing, handling, and storage of EVs. EVs have significant diagnostic and therapeutic potential, but clinical application is limited by disparate methods of data collection. This standardized protocol is scalable and ensures efficient recovery of physiologically intact EVs that may be used in a variety of downstream biochemical and functional analyses. Simultaneous measurement quantifies EV concentration and size distribution absolutely. Absolute quantification corrects for variations in EV number and size, offering a novel method of standardization in downstream applications.

Indexed as

Extracellular VesiclesChromatography, GelReproducibility of Results

Identifiers

PMID37115777
PMCPMC10146456
OpenAlexW4367299052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.